How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
Further information is available on the company's website: http://jabil.com.
Jabil Contact: Ken Darby Jabil Circuit 10560 Dr. Martin Luther King Jr. Street North St. Petersburg, Florida 33716 Tel.: 1-727-803-5755 Email: firstname.lastname@example.org
About Carl Zeiss
Carl Zeiss is a leading international group of companies operating worldwide in the optical and opto-electronic industry. Carl Zeiss AG is headquartered in Oberkochen, Germany.
The business groups, which each operate with sole responsibility, are generally ranked first or second in the strategic markets of biosciences and medical technology, system solutions for industry and optical consumer goods. They offer products and services for biomedical research and medical technology, system solutions for the semiconductor, automotive and mechanical engineering industries, as well as high-quality consumer goods such as camera lenses and binoculars. In fiscal year 2004/05 (ended September 30) the Carl Zeiss Group generated revenues totaling EUR 2,222 million. It employs 11,500 people across the globe, including 3,300 outside Germany. The Carl Zeiss Group is directly represented in more than 30 countries and operates production facilities in Europe, America and Asia.
The eyeglass business has been merged with the US company Sola International and now operates as Carl Zeiss Vision International GmbH. This company is owned 50:50 by Carl Zeiss AG and a private equity company.
Jena-based Zeiss subsidiaries -- Carl Zeiss Jena GmbH, Carl Zeiss Meditec AG and Carl Zeiss SMS GmbH -- generated total revenue of EUR 344 million in fiscal year 2004/2005 (October 1 to September 30) with a workforce of approximately 1600 employees. The portfolio of Carl Zeiss in Jena covers the major future markets of life sciences, ophthalmology, display technologies and semiconductor fabrication.